NLSP logo

NLS Pharmaceutics AG (NLSP) EBIT

Annual EBIT

-$12.03 M
+$4.37 M+26.64%

01 December 2023

NLSP EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NLSP EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+26.6%--
3 y3 years-357.7%--
5 y5 years-196.1%--

NLSP EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-357.7%+26.6%
5 y5 years-357.7%+26.6%
alltimeall time-357.7%+26.6%

NLS Pharmaceutics AG EBIT History

DateAnnualQuarterlyTTM
Dec 2023
-$12.03 M(-26.6%)
-
-
Dec 2022
-$16.39 M(+38.0%)
-
-
Dec 2021
-$11.88 M(+352.0%)
-
-
DateAnnualQuarterlyTTM
Dec 2020
-$2.63 M(-43.2%)
-
-
Dec 2019
-$4.63 M(+13.9%)
-
-
Dec 2018
-$4.06 M(-29.6%)
-
-
Dec 2017
-$5.77 M
-
-

FAQ

  • What is NLS Pharmaceutics AG annual earnings before interest & taxes?
  • What is the all time high annual EBIT for NLS Pharmaceutics AG?
  • What is NLS Pharmaceutics AG annual EBIT year-on-year change?

What is NLS Pharmaceutics AG annual earnings before interest & taxes?

The current annual EBIT of NLSP is -$12.03 M

What is the all time high annual EBIT for NLS Pharmaceutics AG?

NLS Pharmaceutics AG all-time high annual earnings before interest & taxes is -$2.63 M

What is NLS Pharmaceutics AG annual EBIT year-on-year change?

Over the past year, NLSP annual earnings before interest & taxes has changed by +$4.37 M (+26.64%)